SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 232 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,092,435 | -67.2% | 1,232,996 | -42.0% | 0.00% | -100.0% |
| Q3 2022 | $3,335,000 | +34.5% | 2,124,254 | +72.2% | 0.00% | – |
| Q2 2022 | $2,479,000 | -53.0% | 1,233,422 | -45.5% | 0.00% | -100.0% |
| Q1 2022 | $5,275,000 | -54.0% | 2,263,822 | -8.3% | 0.00% | -50.0% |
| Q4 2021 | $11,478,000 | -9.3% | 2,468,523 | +48.8% | 0.00% | 0.0% |
| Q3 2021 | $12,661,000 | -34.7% | 1,659,355 | -17.1% | 0.00% | -50.0% |
| Q2 2021 | $19,391,000 | +18.1% | 2,001,123 | +0.8% | 0.00% | 0.0% |
| Q1 2021 | $16,421,000 | +44.4% | 1,985,678 | +19.2% | 0.00% | +33.3% |
| Q4 2020 | $11,373,000 | -36.2% | 1,666,480 | +4.2% | 0.00% | -40.0% |
| Q3 2020 | $17,838,000 | +122.4% | 1,599,878 | +25.2% | 0.01% | +66.7% |
| Q2 2020 | $8,022,000 | +1956.9% | 1,277,569 | +501.8% | 0.00% | – |
| Q1 2020 | $390,000 | +17.1% | 212,300 | +115.5% | 0.00% | – |
| Q4 2019 | $333,000 | -52.4% | 98,500 | -69.9% | 0.00% | – |
| Q3 2019 | $700,000 | -35.8% | 327,065 | -19.9% | 0.00% | – |
| Q2 2019 | $1,091,000 | +187.1% | 408,413 | +410.7% | 0.00% | – |
| Q1 2019 | $380,000 | -49.1% | 79,965 | -74.3% | 0.00% | – |
| Q4 2018 | $746,000 | +143.8% | 310,675 | +346.3% | 0.00% | – |
| Q3 2018 | $306,000 | -79.8% | 69,607 | -66.9% | 0.00% | – |
| Q2 2018 | $1,513,000 | +302.4% | 210,182 | +187.6% | 0.00% | – |
| Q1 2018 | $376,000 | +683.3% | 73,079 | +480.6% | 0.00% | – |
| Q4 2017 | $48,000 | -14.3% | 12,586 | -61.5% | 0.00% | – |
| Q3 2017 | $56,000 | -27.3% | 32,723 | +68.0% | 0.00% | – |
| Q1 2017 | $77,000 | -29.4% | 19,476 | +38.1% | 0.00% | – |
| Q3 2016 | $109,000 | -56.6% | 14,100 | -51.0% | 0.00% | – |
| Q4 2015 | $251,000 | +2181.8% | 28,792 | +2015.5% | 0.00% | – |
| Q3 2015 | $11,000 | -99.1% | 1,361 | -98.0% | 0.00% | -100.0% |
| Q2 2015 | $1,202,000 | +36.6% | 68,191 | -10.4% | 0.00% | 0.0% |
| Q1 2015 | $880,000 | – | 76,137 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| B. Riley Financial, Inc. | 5,216,250 | $4,621,598 | 1.04% |
| B. Riley Securities, Inc. | 5,216,250 | $4,621,598 | 1.00% |
| EMFO, LLC | 209,398 | $185,527 | 0.19% |
| Wellspring Financial Advisors, LLC | 483,551 | $428,426 | 0.14% |
| Mayo Clinic | 300,000 | $267,000 | 0.14% |
| swisspartners Ltd. | 110,000 | $97,465 | 0.12% |
| Donald L. Hagan, LLC | 169,514 | $150,189 | 0.09% |
| Oaktree Fund Advisors, LLC | 66,000 | $58,476 | 0.09% |
| EUDAIMONIA ADVISORS LLC | 138,887 | $123,054 | 0.08% |
| Asset Management Resources, LLC | 138,020 | $122,286 | 0.08% |